Navigation Links
Discovery could lead to better control of hemorrhagic fever viruses

Researchers report discovering the receptor through which a group of life-threatening hemorrhagic fever viruses enter and attack the body's cells, and show that infection can be inhibited by blocking this receptor. The findings, to be published online by the journal Nature on February 7, give a clue to the high lethality of New World arenaviruses, suggest a way of reducing the severity of infection, and point the way toward a sorely needed treatment strategy.

The four viruses, known as the Machupo, Guanarito, Junin and Sabia viruses, cause Bolivian, Venezuelan, Argentine and Brazilian hemorrhagic fever, respectively, with mortality rates of about 30 percent. No vaccine is available, though a weakened form of Junin virus has been given to Argentinean farmers with some success. In addition to causing occasional disease outbreaks, mostly in poor, rural areas of South America, the viruses are of U.S. government interest because of their potential as bioterrorism agents. All four are classified as NIAID Category A Priority Pathogens and must be handled in Biosafety Level 4 containment facilities.

The researchers, led by Hyeryun Choe, PhD, of Children's Hospital Boston's Pulmonary Division, and Michael Farzan, PhD, of Harvard Medical School (HMS), first investigated the Machupo virus. To identify its cellular receptor, they made copies of the "spike" protein, used by the virus to gain entry into cells, and added it to cells from African green monkeys, known to be highly susceptible to Machupo virus infection. Later, they broke the cells open and isolated the spike protein and the cellular protein to which it had attached itself. Then, using a technique called mass spectrometry, they analyzed this attached cellular protein to determine its identity.

The receptor, identified in Choe's lab by Jonathan Abraham, PhD, an MD-PhD student at HMS, turned out to be transferrin receptor 1 (TfR1), a well-known protein that is key in enabling cells to take
'"/>

Source:Children's Hospital Boston


Page: 1 2 3

Related biology news :

1. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
2. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
3. UCSD Discovery Shows How Embryonic Stem Cells Perform Quality Control Inspections
4. Discovery Could Lead To Novel Approaches In HIV Treatment
5. Discovery Promises Simpler Therapy for Sickle Cell Disease
6. Discovery may lead to better Candidiasis drug
7. Protein Discovery Could Unlock The Secret To Better TB Treatment
8. Discovery clarifies role of peptide in biological clock
9. Eliminate Data Analysis Bottlenecks in Drug Discovery
10. Discovery of New Dopamine Action May Yield Alternative Psychiatric Drugs
11. Discovery could be key to bioterrorism defense

Post Your Comments:
(Date:11/30/2009)... 30 Neurotechnology ( http://www.n... biometric identification technologies, has releas...line: VeriLook 4.0 Software Development Kit (SDK... for large-scale multi-biometric and automated fin...apabilities in VeriLook 4.0 provide enhanced facia...
(Date:11/26/2009)...untries has shown that closing schools in the even...ignificant role in reducing illness transmission. ...C Infectious Diseases compared opportunities for ...nding that they were reduced when schools are shut...ty, Belgium, led a team of European researchers in...
(Date:11/25/2009)...h, may be used to boost resistance to, or slow, th...of Medicine researchers report in a study publishe...e . , Parkinson,s disease is caused by a degener...in known as the substantia nigra, which is respons...of dopamine in late-stage Parkinson,s causes sympt...
Breaking Biology News(10 mins):New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3School closure could reduce swine flu transmission by 21 percent 2Hormone ghrelin can boost resistance to Parkinson's disease 2MedPro Imaging Acquires MC Ultrasound 6131 1MedPro Imaging Acquires MC Ultrasound 6131 2Sigma Aldrich Enters Distribution Agreement With Stemgent Inc to Offer Lentivirus Based Gene Delivery Products for Regenerative Medicine and Stem Ce 6123 1Sigma Aldrich Enters Distribution Agreement With Stemgent Inc to Offer Lentivirus Based Gene Delivery Products for Regenerative Medicine and Stem Ce 6123 2Sigma Aldrich Enters Distribution Agreement With Stemgent Inc to Offer Lentivirus Based Gene Delivery Products for Regenerative Medicine and Stem Ce 6123 3NHLBI publishes new heart healthy cookbook 61061 1NHLBI publishes new heart healthy cookbook 61061 2
...cell, Inc., a stem cell engineering company, today...876 with claims covering human definitive endoderm...pancreatic type cells, which Novocell is developin... other endoderm lineage-derived tissues and organs...id. , "This composition patent is a milestone a...
...aboratory rats suggest that supplementation of the...in lowering triglycerides, which along with choles... risk factors in cardiovascular disease. , In the...riglyceride levels up to 60 percent. If the effect...that would be a greater impact than found with oth...
...h that could help everyone from bed-ridden patient...sincluding 2007 Nobel Prize winner Mario R. Capecc... light signals to be turned on in muscle stem cell...l. For humans, this work could lead to a genetic s...cle cells to replace those that are damaged, worn ...
Other Biology News:New approach discovered to lowering triglycerides 2New approach discovered to lowering triglycerides 3Stem cell breakthrough: Monitoring the on switch that turns stem cells into muscle 2
(Date:11/30/2009)..., Nov. 30 Dr. Jessica Torrente, As...n University Medical Center in Washington, D.C., d...ific Gamma Imaging (BSGI) in clinical practice as ...reast cancer today at the annual meeting of the Ra..."The purpose of the exhibit was to demonstrate how...
(Date:11/30/2009)...SEATTLE, Nov. 30 Cell Th...unced today that its new class of platinum-based a...trated a stronger anti-tumor potency and activity ...pounds as well as the ability to overcome cisplati...re presented in a paper titled "Novel Bis-platinum...
(Date:11/29/2009)... available in German . , The concept of con...sics. The most famous example is that of quarks wh...w Prof. Bella Lake from Helmholtz-Zentrum Berlin t...eport for the first time an experimental realizati...in a condensed matter system. , The concept of c...
(Date:11/26/2009)...TE, Ind. - A new generation of ultrasmall transist...ructures called semiconducting nanowires are close...at IBM, Purdue University and the University of Ca...learned how to create nanowires with layers of dif...tomic level, which is a critical requirement for m...
Breaking Biology Technology:Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Spinons -- confined like quarks 2Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3
...ion, Inc.,(Nasdaq: MDVN ) today announced that th...rust Improvements Act for its collaboration with,P...collaboration,Medivation and Pfizer have agreed to... treatment of Alzheimer,s disease and Huntington,s...s an up-front payment to Medivation,of $225 millio...
...can help detect ,silent killers, such as he...osis, Screenings provide potentially life-saving ...iled measurements for clients and their doctors ... population, AUSTIN, Texas, Oct. 22 HealthYes!(T...e preventive medical screenings which can,help det...
...20th EORTC-NCI-AACR Symposium -, SOUTH SAN FRANCI...all/,-- Poniard Pharmaceuticals, Inc. (Nasdaq: PA...ogy, today announced positive incremental data fro... in combination with,docetaxel and prednisone as f...y prostate cancer (HRPC). The expanded and updated...
Other Biology Technology:Medivation Announces Expiration of Hart-Scott-Rodino Waiting Period for Collaboration With Pfizer 2HealthYes! - Premier Provider of Mobile Preventive Medical Screenings - Launches in Alamo City 2HealthYes! - Premier Provider of Mobile Preventive Medical Screenings - Launches in Alamo City 3HealthYes! - Premier Provider of Mobile Preventive Medical Screenings - Launches in Alamo City 4HealthYes! - Premier Provider of Mobile Preventive Medical Screenings - Launches in Alamo City 5HealthYes! - Premier Provider of Mobile Preventive Medical Screenings - Launches in Alamo City 6HealthYes! - Premier Provider of Mobile Preventive Medical Screenings - Launches in Alamo City 7Poniard Announces Positive Incremental Efficacy and Safety Data From Ongoing Phase 2 Picoplatin Trial in Hormone-Refractory Prostate Cancer 2Poniard Announces Positive Incremental Efficacy and Safety Data From Ongoing Phase 2 Picoplatin Trial in Hormone-Refractory Prostate Cancer 3Poniard Announces Positive Incremental Efficacy and Safety Data From Ongoing Phase 2 Picoplatin Trial in Hormone-Refractory Prostate Cancer 4Poniard Announces Positive Incremental Efficacy and Safety Data From Ongoing Phase 2 Picoplatin Trial in Hormone-Refractory Prostate Cancer 5
...L) can provide you with the expertise developed ov...ent and validation ,Performance of methods used ...g environment ,Assurance of quality for manufact...microbiological services to the pharmaceutical ind...
...ide whose sequence is from rat SCAMP 5. The seque...: C - N(217) - Q - P - Q - T - Q - Y - S - A - T ...ay be used for neutralization and control experime...this product and the rat SCAMP 5, catalog # PA1-73...
..., After we receive your antigen (see How to Prep...mber of chickens and begin to collect pre-immune e... a period of 3-5 days), we begin the injection ser... the breast muscle. The first is in Complete Freun...
... exists? Having difficulty generating antibodies i...of pharmaceutical, biotech and academic researcher...expertise in antibody generation to work for you. ...nology , High affinity and high specificity , High...
Biology Products: